Clinician's Handbook App - Targeting FH
Familial hypercholesterolaemia (FH) is the most common inherited metabolic condition, affecting about
one in 200 people. As highlighted by the EAS Consensus Panel, FH is seriously underdiagnosed and undertreated. This new App, available for iPad and iPhone, and authored by members of the Panel, provides an
important resource to tackle these issues. Detection, diagnosis, screening and management of FH are discussed, with emphasis on targeting children with FH to optimise benefit and reduce premature heart
disease. Supported by an Unrestricted Educational Grant from SANOFI and REGENERON.
Available to download at the apple store >>
Think Again About Cholesterol
EAS have announced results from the Think Again About Cholesterol survey of more than 12,000 adults on their understanding of high cholesterol. The survey
results, conducted online on behalf of EAS by Harris Poll, a leading global provider of information and analytics, and sponsored by Sanofi and Regeneron Pharmaceuticals, Inc., found a major discrepancy
between understanding the importance of high cholesterol and taking action against this major risk factor for cardiovascular disease (CVD). EAS found that although 89 percent of adults surveyed agreed it is
important to know whether or not they have high low-density lipoprotein cholesterol (LDL-C), 92 percent did not know their cholesterol levels or never had their cholesterol levels tested. Other findings
include what health concerns most people are worried about, familiarity with CVD terminology and more.
Read about the results on the EAS website >>
Certificate of Education in Familial Hypercholesterolaemia
New on EAS Academy - an online course for healthcare professionals meeting people with FH. Through a curriculum of presentations, quizzes and case studies
the EAS Certificate of Education in Familial Hypercholesterolaemia gives a broad knowledge about the most common genetic dyslipidaemia, Familial Hypercholesterolaemia (FH). The course gives insight into the
genetics of the disease, the basic molecular mechanisms and the clinical development. It also covers how to practically handle FH patients, FH in childhood and the family of FH patients.
More information about the Course >>